나노로보틱스 시장 : 유형별(나노매니퓰레이터, 나노로보틱 시스템), 적용별(생체내, 시험관내/생체외), 기술별(자기 구동, 바이오하이브리드), 용도별(의료, 분자 제조), 최종사용자별 - 세계 예측(-2036년)

Nanorobotics Market by Type (Nano-Manipulators, Nanorobotic Systems), Deployment (In-Vivo, In-Vitro/Ex-Vivo), Technology (Magnetic Actuation, Biohybrid Propulsion), Application (Healthcare, Molecular Manufacturing), End-User (Hospitals & Clinical Centers, Research Institutions, Pharmaceutical Companies), and Geography - Global Forecast to 2036

According to the research report titled, 'Nanorobotics Market by Type (Nano-Manipulators, Nanorobotic Systems), Deployment (In-Vivo, In-Vitro/Ex-Vivo), Technology (Magnetic Actuation, Biohybrid Propulsion), Application (Healthcare, Molecular Manufacturing), End-User (Hospitals & Clinical Centers, Research Institutions, Pharmaceutical Companies), and Geography - Global Forecast to 2036,' the global nanorobotics market is expected to reach approximately USD 31.19 billion by 2036 from USD 8.27 billion in 2026, at a CAGR of 14.2% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global nanorobotics market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.

The major factors driving the growth of the nanorobotics market include the intensifying global focus on precision medicine and the rapid expansion of autonomous molecular systems. Additionally, the integration of AI-driven nanomedicine, increasing demand for real-time cellular-level intervention, and expansion of advanced nanorobotic platforms are expected to create significant growth opportunities for players operating in the nanorobotics market.

Market Segmentation

The nanorobotics market is segmented by type (nano-manipulators, nanorobotic systems), deployment (in-vivo, in-vitro/ex-vivo), technology (magnetic actuation, biohybrid propulsion), application (healthcare, molecular manufacturing), end-user (hospitals & clinical centers, research institutions, pharmaceutical companies), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Type

By type, the nanorobotic systems segment holds the largest market share in 2026, primarily attributed to their comprehensive functionality in supporting targeted drug delivery and in-vivo diagnostics. Nanorobotic systems provide integrated solutions for complex medical applications. However, the nano-manipulators segment is expected to grow at the fastest CAGR during the forecast period, driven by the increasing demand for precision molecular assembly and structural manipulation at the nanoscale. The ability to deliver integrated solutions with proven clinical validation makes advanced nano-manipulator platforms highly attractive for research and pharmaceutical applications.

Based on Deployment

By deployment, the in-vitro/ex-vivo segment holds the largest market share in 2026, owing to its widespread adoption in laboratory research environments and pharmaceutical development workflows. In-vitro systems provide controlled environments for nanorobotic experimentation. The in-vivo segment is expected to witness significant growth during the forecast period, driven by the increasing demand for minimally invasive therapeutic interventions and real-time diagnostic capabilities. Advanced in-vivo nanorobotics represent an emerging frontier with tremendous potential for precision medicine applications.

Based on Technology

By technology, the magnetic actuation segment holds the largest share of the overall market in 2026, due to its proven effectiveness in enabling precise control and navigation of nanorobotic systems. Magnetic actuation provides reliable, non-invasive control mechanisms for nanoscale devices. The biohybrid propulsion segment is expected to grow at a significant CAGR during the forecast period, driven by the increasing adoption of biological propulsion systems and hybrid nanorobotic architectures. Advanced technology integration continues to enhance the capabilities and performance of nanorobotic systems.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. In 2026, North America dominates the global nanorobotics market with the largest market share, primarily attributed to massive investments in healthcare innovation and the presence of leading research institutions and pharmaceutical companies in the United States and Canada. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by aggressive government funding and the rapid adoption of advanced nanotechnologies in China, India, and Japan. Europe, Latin America, and the Middle East & Africa represent emerging markets with growing research infrastructure and increasing adoption of nanorobotic technologies.

Key Players

The key players operating in the global nanorobotics market are Calando Pharmaceuticals, Genentech (Roche), Arrowhead Research Corporation, Luna Innovations, NanoHorizon, Altair Nanotechnologies, Harris & Harris Group, and various other regional and emerging nanotechnology and healthcare innovation companies, among others.

Key Questions Answered in the Report-

• What is the current revenue generated by the nanorobotics market globally?
• At what rate is the global nanorobotics market demand projected to grow for the next 7-10 years?
• What are the historical market sizes and growth rates of the global nanorobotics market?
• What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
• Which segments in terms of type, deployment, technology, and application are expected to create major traction for the service providers in this market?
• What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global nanorobotics market?
• Who are the major players in the global nanorobotics market? What are their specific product offerings in this market?
• What are the recent strategic developments in the global nanorobotics market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Nanorobotics Market Assessment -- by Type

• Nano-Manipulators
• Nanorobotic Systems

Nanorobotics Market Assessment -- by Deployment

• In-Vivo
• In-Vitro/Ex-Vivo

Nanorobotics Market Assessment -- by Technology

• Magnetic Actuation
• Biohybrid Propulsion

Nanorobotics Market Assessment -- by Application

• Healthcare
• Molecular Manufacturing

Nanorobotics Market Assessment -- by End-User

• Hospitals & Clinical Centers
• Research Institutions
• Pharmaceutical Companies

Nanorobotics Market Assessment -- by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Scope
• 1.3. Research Methodology
• 1.4. Assumptions & Limitations

2. Executive Summary

3. Market Overview

• 3.1. Introduction
• 3.2. Market Dynamics
  • 3.2.1. Drivers
  • 3.2.2. Restraints
  • 3.2.3. Opportunities
  • 3.2.4. Challenges
• 3.3. Market Trends

4. Global Nanorobotics Market, by Type

• 4.1. Introduction
• 4.2. Nano-manipulators
  • 4.2.1. Atomic Force Microscopes (AFM)
  • 4.2.2. Scanning Tunneling Microscopes (STM)
  • 4.2.3. Others
• 4.3. Nanorobotic Systems
  • 4.3.1. Bio-nanorobots
  • 4.3.2. Magnetically Guided Nanorobots
  • 4.3.3. Electromechanical Nanobots
  • 4.3.4. Others
• 4.4. Software & Control Systems

5. Global Nanorobotics Market, by Deployment

• 5.1. Introduction
• 5.2. In-vivo Deployment
  • 5.2.1. Targeted Drug Delivery
  • 5.2.2. Surgical Interventions
  • 5.2.3. Diagnostic Imaging
  • 5.2.4. Tissue Engineering & Repair
  • 5.2.5. Other In-vivo Applications
• 5.3. In-vitro/Ex-vivo Deployment
  • 5.3.1. Laboratory Research
  • 5.3.2. Drug Discovery
  • 5.3.3. Diagnostics & Testing
  • 5.3.4. Other In-vitro Applications

6. Global Nanorobotics Market, by Technology

• 6.1. Introduction
• 6.2. Magnetic Actuation
  • 6.2.1. Electromagnetic Field Systems
  • 6.2.2. Permanent Magnet Systems
  • 6.2.3. Hybrid Magnetic Systems
• 6.3. Biohybrid/Biological Propulsion
  • 6.3.1. Cell-based Propulsion
  • 6.3.2. Biological Motor Systems
  • 6.3.3. Hybrid Bio-synthetic Systems
• 6.4. Acoustic/Ultrasound Propulsion
  • 6.4.1. Ultrasonic Actuation
  • 6.4.2. Acoustic Streaming
  • 6.4.3. Resonance-based Systems
• 6.5. Optical/Light-driven Actuation
  • 6.5.1. Photonic Propulsion
  • 6.5.2. Optogenetic Control
  • 6.5.3. Plasmonic Systems
• 6.6. Other Technologies

7. Global Nanorobotics Market, by Application

• 7.1. Introduction
• 7.2. Healthcare
  • 7.2.1. Drug Delivery
  • 7.2.2. Diagnostics & Imaging
  • 7.2.3. Nanosurgery & Tissue Repair
  • 7.2.4. Dental Applications
  • 7.2.5. Other Healthcare Applications
• 7.3. Molecular Manufacturing
• 7.4. Research & Development
• 7.5. Environmental Monitoring
• 7.6. Industrial & Electronics

8. Global Nanorobotics Market, by End-User

• 8.1. Introduction
• 8.2. Hospitals & Clinical Centers
• 8.3. Pharmaceutical & Biotechnology Companies
• 8.4. Academic & Research Institutes
• 8.5. Medical Device OEMs
• 8.6. Industrial Manufacturers
• 8.7. Other End-Users

9. Global Nanorobotics Market, by Geography

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. U.K.
  • 9.3.3. France
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Switzerland
  • 9.3.7. Rest of Europe
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. South Korea
  • 9.4.5. Australia & New Zealand
  • 9.4.6. Rest of Asia-Pacific
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Argentina
  • 9.5.4. Chile
  • 9.5.5. Colombia
  • 9.5.6. Rest of Latin America
• 9.6. Middle East & Africa
  • 9.6.1. GCC Countries
    • 9.6.1.1. Saudi Arabia
    • 9.6.1.2. UAE
    • 9.6.1.3. Qatar
    • 9.6.1.4. Rest of GCC
  • 9.6.2. South Africa
  • 9.6.3. Israel
  • 9.6.4. Egypt
  • 9.6.5. Nigeria
  • 9.6.6. Rest of Middle East & Africa

10. Competitive Landscape

• 10.1. Introduction
• 10.2. Key Player Strategies
• 10.3. Competitive Dashboard
  • 10.3.1. Industry Leader
  • 10.3.2. Market Differentiators
  • 10.3.3. Vanguards
  • 10.3.4. Emerging Companies
• 10.4. Market Share Analysis, By Key Player

11. Company Profiles

• 11.1. JEOL Ltd. (Japan)
• 11.2. Thermo Fisher Scientific Inc. (US)
• 11.3. Bruker Corporation (Germany)
• 11.4. Hitachi High-Tech Corporation (Japan)
• 11.5. ZEISS Group (Germany)
• 11.6. Oxford Instruments (UK)
• 11.7. Imina Technologies (Switzerland)
• 11.8. SmarAct GmbH (Germany)
• 11.9. Stereotaxis, Inc. (US)
• 11.10. Ginkgo Bioworks (US)
• 11.11. EV Group (Austria)

12. Appendix

• 12.1. Questionnaire
• 12.2. Available Customization